|
|
United
States
Patent
|
20040009245
|
|
Vail, William Banning III ; et al. |
January 15, 2004 |
| |
|
|
Methods and apparatus to prevent, treat and cure infections of
the human
respiratory system by pathogens causing severe acute respiratory syndrome (SARS)
Abstract
Concentrated vapors from botanical essential oils are inhaled to prevent, treat
and cure infections of the respiratory pathogens causing Severe Acute
Respiratory Syndrome ("SARS"). These vapors are inhaled as a practical method to
reduce the risks of infection by the pathogens causing SARS in crowded public
places. These vapors are also inhaled as a practical method to reduce the risks
of infection by unknown, and unpredictable, respiratory pathogens that may be
present in public places. The essential oils have antiseptic properties, are
safe to inhale, and include, but are not limited to, the essential oils from
Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and
Eucalyptus radiata. Convenient hand-held inhaler apparatus are provided for the
inhalation of concentrated vapors from the antiseptic essential oils and other
substances. The antiseptic essential oils have selected antiviral,
antibacterial, and antifungal properties.
|
|
Inventors: |
Vail,
III;
William
Banning
(Bothell,
WA);
Vail;
Marilyn
L.
(Bothell,
WA) |
|
Correspondence Name and Address:: |
WILLIAM BANNING VAIL III
3123 198TH PLACE SE
BOTHELL
WA
98012
US |
|
Serial No.: |
429077 |
Series Code: 10 |
Filed: May 2, 2003 |
U.S. Current Class: |
|
Current
U.S.
Class: |
424/742 |
|
Intern'l
Class:
|
A61K 035/78 |
|
|
|
What is claimed is:
1. A method to reduce the risks of infection of the human respiratory system by
pathogens causing Severe Acute Respiratory Syndrome (SARS) in an enclosed public
area having one or more human beings within said public area comprising the
following steps:
(a) within a period of time of 30 minutes before entering said
public area, inhaling an effective amount of the concentrated vapors from
Eucalyptus globulus; and
(b) after entering said public area, periodically
inhaling the concentrated vapors from Eucalyptus globulus, whereby the period of
time between successive inhalations exceeds 30 minutes, and whereby the period
of time between successive inhalations is less than 2 hours.
2. The method in
claim 1 whereby said pathogens include at least one strain of a coronavirus.
3. The method in claim 1 whereby said pathogens include at least one strain of a paramyxovirus.
4. The method in claim 1 whereby said pathogens include at least
one strain of a coronavirus in association with at least a selected one of a
strain of paramyxovirus and a strain of chlamydia bacteria.
5. A method to
reduce the risks of infection of the human respiratory system by pathogens
causing Severe Acute Respiratory Syndrome (SARS) in an enclosed public area
having one or more human beings within said public area comprising the following
steps:
(a) within a period of time of 30 minutes before entering said public
area, inhaling an effective amount of the concentrated vapors from an essential
oil that possesses antiseptic properties, whereby said vapors are safe for human
inhalation, and whereby said antiseptic properties include selected antiviral,
selected antibacterial, and selected antifungal properties; and
(b) after
entering said public area, periodically inhaling the concentrated vapors from
said essential oil, whereby the period of time between successive inhalations
exceeds 30 minutes, and whereby the period of time between successive
inhalations is less than 2 hours.
6. The method in claim 5 whereby said
pathogens include at least one variety of coronavirus.
7. The method in claim 5
whereby said pathogens include at least one variety of paramyxovirus.
8. The
method in claim 5 whereby said pathogens include at least one variety of coronavirus in association with at least a selected one of a variety of
paramyxovirus and variety of chlamydia bacteria.
9. The method in claim 5
whereby the essential oil is selected to be one or more from the following list
of essential oils: Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus
citriodora, and Eucalyptus radiata.
10. A method to reduce the risks of
infection of the human respiratory system by unknown respiratory pathogens in an
enclosed public area having one or more human beings within said public area
comprising the following steps:
(a) within a period of time of 30 minutes before
entering said public area, inhaling the concentrated vapors from an essential
oil that possesses antiseptic properties, whereby said vapors are safe for human
inhalation, and whereby said antiseptic properties include selected antiviral,
selected antibacterial, and selected antifungal properties, and whereby the
concentrated vapors from said essential oil are inhaled from a hand-held inhaler
apparatus; and
(b) after entering said public area, periodically inhaling the
concentrated vapors from said essential oil, whereby the period of time between
successive inhalations exceeds 30 minutes, and whereby the period of time
between successive inhalations is less than 2 hours.
11. The method in claim 10
whereby said unknown respiratory pathogens include the pathogen causing Severe
Acute Respiratory Syndrome (SARS).
12. The method in claim 10 whereby said
unknown pathogens include a variety of an influenza virus causing a flu.
13. The
method in claim 10 whereby said unknown pathogens include a variety of a
rhinovirus causing a cold.
14. The method in claim 10 whereby said unknown
pathogens include a variety of the bacterium Staphylococcus aureus that causes
staphylococcal pneumonia.
15. The method in claim 10 whereby said unknown
pathogens include a variety of the bacterium Mycobacterium tuberculosis that
causes tuberculosis.
16. The method in claim 10 whereby said unknown pathogens
include a variety of
the fungus Blastomyces dermatitidis that causes a fungal pneumonia.
17. The
method in claim 10 whereby the essential oil is selected to be one or more from
the following list of essential oils: Eucalyptus globulus, Melaleuca
alternifolia, Eucalyptus citriodora, and Eucalyptus radiata.
18. A method to
prevent the infection of the human respiratory system by unknown pathogens that
includes at least the step of inhaling the concentrated vapors from an essential
oil having antiseptic properties, whereby said vapors are safe to inhale, and
whereby said antiseptic properties include selected antibacterial properties,
selected antiviral properties, and selected antifungal properties.
19. A method
to treat the infection of the human respiratory system by pathogens causing
Severe Acute Respiratory Syndrome (SARS) that includes at least the step of the
inhalation of an effective amount of concentrated from an essential oil having
antiseptic properties, whereby said vapors are safe to inhale, and whereby said
antiseptic properties include selected antibacterial properties, selected
antiviral properties, and selected antifungal properties.
20. The method in
claim 19 whereby said essential oil is comprised of at least a selected one of
Eucalyptus globulus, Melaleuca alternifolia, Eucalyptus citriodora, and
Eucalyptus radiata.
21. The method in claim 19 whereby said essential oil is
comprised of a mixture of one or more of Eucalyptus globulus, Melaleuca
alternifolia, Eucalyptus citriodora, and Eucalyptus radiata.
22. A method to
treat the infection of the human respiratory system by unknown pathogens that
includes at least the step of inhaling concentrated vapors from an essential oil
having antiseptic properties, whereby said vapors are safe to inhale, and
whereby said antiseptic properties include selected antibacterial properties,
selected antiviral properties, and selected antifungal properties.
23. A method
to treat the infection of the human respiratory system by pathogens causing
Severe Acute Respiratory Syndrome (SARS) that includes at least the step of the
inhalation of an effective amount of concentrated vapors from any substance
having antiseptic properties, whereby said vapors are safe to inhale, and
whereby said antiseptic properties include selected antibacterial properties,
selected antiviral properties, and selected antifungal properties. |
|
